Oral Submucous Fibrosis

Oral Submucous Fibrosis: Definition and Affected Population

Understanding Oral Submucous Fibrosis

Oral submucous fibrosis (OSF) is defined as a chronic, progressive, irreversible, and crucially, preventable metabolic disorder of collagen. This condition is triggered by the habit of chewing areca nut contained in betel quid or its various formulations. Clinically, it presents similarities to scleroderma, but its involvement is strictly localized to the oral cavity. Furthermore, its presence increases the risk of developing oral squamous cell carcinoma.

Who Does Oral Submucous Fibrosis Primarily Affect?

Oral submucous fibrosis predominantly affects populations from the Indian subcontinent who consume betel quid or its derivatives, such as gutkha (mitha pan), kiwam, zarda and pan masala.. The sweetened versions of this product consumed by children, known as sweet supari, gua, mawa, or pan mistee, extend the scope of consumption. The high accessibility of pre-packaged dry products, such as gutkha, is raising the incidence of this disease, given that these products possess a higher content of dried areca nut compared to traditional betel leaf (paan) quid. It is important to note that the betel leaf itself might offer some protective effect.

The consumption of betel quid is an addictive habit due to the presence of tobacco and areca nut. Initially, it confers a sensation of euphoria and well-being to the consumer. Traditionally, it has also been valued for its anthelmintic properties (to combat intestinal worms) and as a postprandial digestive aid.

The chewed material is often retained between the teeth and the inner cheek, remaining there for periods ranging from minutes to several hours. Some users swallow the residue, while others spit it out.

The practice of chewing betel quid is observed almost exclusively in the Indian subcontinent, Southeast Asia, and the Western Pacific, as well as in communities that have emigrated from these regions. It is uncommon to report cases in non-Asian individuals residing in Southeast Asia or those married to Asian individuals. The chemical composition of the areca nut varies by region, resulting from differences in cultivation and preparation, which directly impacts the frequency with which oral submucous fibrosis manifests in different populations.

OSF can manifest at any age, with the exception of very young children. The most affected age group ranges between 20 and 40 years. In contrast to traditional betel quid, gutkha consumption usually starts at an earlier age and requires less time for disease progression, which is why cases of OSF have been documented in individuals as young as 11 years old.

Historically, some populations showed a predominance in the female sex, suggesting a possible hormonal influence or a role for iron deficiency. However, more recently, with the immediate availability of pre-packaged commercial formulations, a male predominance is now reported.

The duration of betel quid chewing necessary before oral submucous fibrosis manifests is highly variable, extending from a few months to several years. This duration is likely dependent on the specific composition of the quid, the intensity of the habit, as well as genetic factors and other individual susceptibility.

There are predisposing factors, such as genetic background, that can modulate the development of OSF upon exposure to areca nut. Isolated familial cases have been reported in which affected members did not practice the habit of chewing betel quid. Furthermore, a higher incidence has been identified in certain specific tissue types.

The role of malnutrition is still not completely clear; however, OSF is observed more frequently in lower to middle socioeconomic classes, associated with inadequate nutrition. Similarly, the influence of spices and chilies has been questioned. On the other hand, a high intake of fruits and vegetables has been documented to have a protective effect against the development of this condition.

Clinical Manifestations of Oral Submucous Fibrosis Diagnosis

The first sign of oral submucous fibrosis is a burning sensation in the oral cavity, which intensifies when consuming seasoned or spicy foods; sometimes, this may be accompanied by the appearance of small blisters. Dry mouth along with the presence of ulcers.

During clinical examination, even in initial stages, the mucosa oral mucosa will show a whitish appearance with a marbled pattern. This alteration can present diffusely throughout the mouth or be limited to specific areas, or manifest with a reticular pattern.

As the disease progresses to more advanced stages, evident fibrosis develops:

Oral opening is significantly restricted, which severely compromises the ability to eat, swallow, speak, and maintain adequate dental hygiene.
The tongue becomes flaccid, takes on a white hue, and loses its usual mobility.
The cheeks acquire a firm and thick consistency, preventing their normal distension (they cannot be "puffed out").
The lips become thickened, rubbery, and adopt a typically elliptical morphology.

In the most severe cases, the fibrotic process can extend to the soft palate, pharynx, and the esophagus. esophagus. The uvula may experience retraction and deformation. Difficulty in swallowing may arise, and even obstruction of the Eustachian tubes connecting to the ear may occur, consequently affecting hearing ability.

While much of the inside of the mouth can become fibrotic, fibrotic, the gums are less frequently affected structures. Cases of unilateral involvement have been documented when the use of chewed areca is consistently maintained in a single site. The pattern of involvement is also influenced by whether the chewed bolus is swallowed or spit out. Swallowing exposes the soft palate, throat, and esophagus to the irritant agent, making these posterior areas more susceptible to damage than in people who spit out the residue. Those who tend to spit out the bolus show a greater predisposition to affect the lips and the more anterior areas of the mouth.

It is crucial to highlight that there is an elevated risk of developing carcinoma of squamous cells squamous cells over oral mucosa that exhibits atrophy and thinning. Some scientific reviews have estimated this risk to be as high as 1 in 5 cases.

Clinical Diagnostic Process for Oral Submucous Fibrosis

Generally, the diagnostic process is based on gathering the clinical history regarding areca nut exposure and subsequent physical examination.

Suggested clinical criteria for confirming the condition include the presence of one or more of the following findings:

Presence of significant whitening of the oral mucosa.
Detection of fibrous bands palpable upon palpation.
A texture perceived as hard and leathery in the oral mucosa.

The biopsy Lesions of the < mucosa reveals a < pathology nonspecific in the initial stages, characterized by edema and < inflammation < acute. acute inflammation. However, in established disease, histopathology is much more definitive; thick, dense collagen bands are observed along with a reduction in the number of < blood vessels. The < epithelium blood vessels. The superficial < <">dysplasia epithelium thins, and the presence of muscle degeneration is detectable towards the end of the disease's evolution.

Imaging study techniques such as barium swallow can be useful to evaluate the extent of pharyngeal involvement and possible < It may be feasible to differentiate dyskeratosis congenita through flow cytometry. FISH shows an analysis characterized by significantly shorter telomeres compared to control subjects S..

surgical intervention. In some cases, blood tests may be necessary to determine the patient's general nutritional status and to rule out or confirm the presence of other < are evaluated in patients with suspected connective tissue or autoimmune disease. The efficacy of warfarin (maintaining an international normalized ratio [INR] of 3) has been documented in three specific cases of cutaneous polyarteritis nodosa, observing improvement in livedo reticularis and healing of associated.

Treatment Options for Oral Submucous Fibrosis

Total cessation of the habit of chewing areca nut is essential to minimize the progression of the pathology. However, it is important to note that established fibrosis generally does not show < regression spontaneous regression. Frequent clinical follow-up through periodic examinations is required to detect any development of < cancer. oral cancer early. The extent of mouth opening, measured in millimeters (the normal average is 40 mm), can be used as an objective parameter to monitor both the progression of the disease and the possible response to the applied treatment.

To date, no pharmacological treatment has demonstrated conclusive efficacy in reversing this chronic condition.

The usual therapeutic regimen consists of administering injections of < corticosteroids corticosteroids < When acute hives is caused by reactions similar to serum sickness (such as those following blood transfusions or certain medications), it may be accompanied by ecchymosis (bruising), fever, directly into the fibrotic bands, administered weekly for a cycle of 6 to 8 weeks. Hyaluronidase, an < diseases, enzyme designed to degrade the collagen matrix, can be co-administered with the cortisone. Furthermore, initiating specific mouth-opening exercises is strongly recommended, and management is often supplemented with nutritional supplements. Numerous reports exist regarding the variety of therapies that have been tested to manage this condition.

In situations of advanced disease where functional limitation prevents basic activities, surgical intervention may be necessary to restore a functional degree of oral opening.

Prevention remains the most effective strategy, given that the development of oral submucous fibrosis is an exceptional event when the practice of chewing areca nut does not exist.